Bundamedik Tbk Pt Stock Working Capital
| BMHS Stock | 256.00 4.00 1.54% |
Bundamedik Tbk PT fundamentals help investors to digest information that contributes to Bundamedik Tbk's financial success or failures. It also enables traders to predict the movement of Bundamedik Stock. The fundamental analysis module provides a way to measure Bundamedik Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bundamedik Tbk stock.
Bundamedik |
Bundamedik Tbk PT Company Working Capital Analysis
Bundamedik Tbk's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, Bundamedik Tbk PT has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. The working capital for all Indonesia stocks is 100.0% higher than that of the company.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Bundamedik Fundamentals
| Return On Equity | 0.0811 | |||
| Return On Asset | 0.0465 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 3.68 T | |||
| Shares Outstanding | 8.6 B | |||
| Shares Owned By Insiders | 78.80 % | |||
| Price To Book | 2.14 X | |||
| Price To Sales | 2.17 X | |||
| Revenue | 1.71 T | |||
| Gross Profit | 799.78 B | |||
| EBITDA | 291.45 B | |||
| Net Income | 215.3 B | |||
| Total Debt | 225.96 B | |||
| Book Value Per Share | 186.41 X | |||
| Cash Flow From Operations | 260.04 B | |||
| Earnings Per Share | 30.71 X | |||
| Target Price | 855.0 | |||
| Number Of Employees | 1.16 K | |||
| Market Capitalization | 3.61 T | |||
| Total Asset | 2.69 T | |||
| Z Score | 9.0 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 2.69 T | |||
| Last Dividend Paid | 2.56 |
About Bundamedik Tbk Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bundamedik Tbk PT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bundamedik Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bundamedik Tbk PT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bundamedik Stock
Bundamedik Tbk financial ratios help investors to determine whether Bundamedik Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bundamedik with respect to the benefits of owning Bundamedik Tbk security.